Choosing Cancer Weapons With the Best Aim
In oncology, we do the best we can. We give drugs with 10-20% chances of working because we have nothing …
The Insider's Guide to Translational Medicine
An exploration of the future of clinical hematology and oncology through precision medicine, drug development, and artificial intelligence.
Editorial column by Dr. Basem Goueli
Wielding New Cancer Weapons Forged in Cell-Free DNA: A Wake Up Call For The Entire Biotech Industry
Advances in computational biology, precision medicine, artificial intelligence/machine learning, etc., are launching us into a world where strategic control points …
Drowning in Data: A Data Science Primer for a Translational Scientist
In 1945 the volume of human knowledge doubled every 25 years. Now, that number is 12 hours [1]. With our …
Hunting Cancer Before It Can Hunt You: A Bird's Eye View of Cell-Free DNA Market Trends
Chapter 2 of a Hitchhiker's Guide to Cell-Free DNA. By the end of 2022, there will be an estimated 609,360 …
Predicting a Patient’s Future with a Crystal Ball Comprised of Cell-free DNA
Chapter 1 of a 3-chapter Hitchhiker’s guide to cell-free DNA for travelers of all backgrounds and expertise. Even though I’ve …
Quarterbacking a Patient's Fight Against Cancer
In the incredibly competitive world of drug development, comprehensive precision, and healthtech, every strategic control point is essential. Over the …
Playing Chess Against Cancer: A Pharmaceutical, Biotechnological, and Clinical Guide to Modern Day Oncologic Treatment Cartography
We are witnessing a revolution in cancer therapeutics that is truly bewildering. The number of novel drugs with unique mechanisms …
Conducting a Cellular Symphony With Life Saving Combination Therapies
I always think of the Jeff Goldblum quote in Jurassic Park where he says "life finds a way" when I …
